Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

March 31, 2018

Conditions
Heart Failure
Interventions
DEVICE

HeartWare® VAS

The HeartWare® LVAD is an implantable centrifugal pump that was designed to provide flows up to 10 L/min in a small device which is both lightweight and simple to use.

Trial Locations (25)

10467

Montefiore Medical Center, The Bronx

15213

University of Pittsburgh Medical Center, Pittsburgh

17033

Milton S. Hershey Medical Center, Hershey

19104

Hospital of the University of Pennsylvania, Philadelphia

20010

Washington Hospital Center, Washington D.C.

27710

Duke University Medical Center, Durham

30322

The Emory Clinic Inc., Atlanta

32610

University of Florida - Gainesville, Gainesville

33136

University of Miami / Jackson Memorial Hospital, Miami

40202

Jewish Hospital - Rudd Heart and Lung Institute, Louisville

43210

Ohio State University Medical Center, Columbus

44195

Cleveland Clinic Foundation, Cleveland

46202

IU Health Methodist, Indianapolis

48109

University of Michigan Hospital, Ann Arbor

48202

Henry Ford Hospital, Detroit

55455

University of Minnesota, Minneapolis

60453

Advocate Christ Medical Center, Oak Lawn

60611

Northwestern Memorial Hospital, Chicago

60637

University of Chicago, Chicago

63110

Washington University / Barnes Jewish Hospital, St Louis

75390

University of Texas - South Western, Dallas

77030

Texas Heart Institute, Houston

94305

Stanford University School of Medicine, Stanford

99204

Northwest Cardiothoracic &Transplant Surgeons, Spokane

02111

Tufts Medical Center, Boston

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01832610 - Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials | Biotech Hunter | Biotech Hunter